Thus, the low frequency of BRAF mutations we observed among Middle Easterners may reflect a primary predilection among this racial group towards BRAF-WT lesions, or may instead simply reflect the low frequency of CIMP in Middle Easterners that is essential for the progression to cancer of BRAF-mutant lesions. This evidence concerns the gene BRAF and cancer.